|Bid||17.18 x 50000|
|Ask||17.51 x 50000|
|Day's Range||17.18 - 17.18|
|52 Week Range||14.81 - 19.02|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.21 (1.19%)|
|Ex-Dividend Date||Mar 30, 2022|
|1y Target Est||N/A|
Élargir son domaine de chirurgie mini-invasive en renforçant l'activité orthopédique Tokyo, Japon & Hambourg, Allemagne--(Newsfile Corp. - 2 novembre 2020) - Olympus Corporation (Director, Representative Executive Officer, President et CEO: Yasuo Takeuchi) a annonce aujourd'hui avoir acquis FH ORTHO SAS, une societe internationale de produits orthopediques dont le siege est a Heimsbrunn, en France, a la suite de la conclusion d'un accord definitif que les deux societes avaient initie a l'ete 2020\. Cette acquisition ...
To expand Minimally Invasive Surgery field by reinforcing its orthopedics business Tokyo, Japan & Hamburg, Germany--(Newsfile Corp. - November 2, 2020) - Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced that it has acquired FH ORTHO SAS, an international orthopedic company headquartered in Heimsbrunn, France, following the close of a definitive agreement the two companies signed in the summer of 2020. The acquisition underscores Olympus' commitment to expanding in ...
President Donald Trump's handling of the coronavirus outbreak early this year was "an incredible gift" for investors because it kept markets stable long enough for some to protect their portfolios, Axon Capital co-founder Dinakar Singh told investors this month. Trump has justified his public assurances that the virus will quickly go away by arguing he needs to be "a cheerleader" for the United States to avoid creating "havoc and shock." "We simply never believed 'what happens in China stays in China,'" Singh wrote in a letter to investors last week that was seen by Reuters.